DotBio

DotBio

Biotechnology Research Singapore, Central Singapore, Sg 19 employees
Employees
19
Contacts
2
Emails
2

DotBio Overview

Headquarters
Singapore, Central Singapore, Sg
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
19
Founded
2018
Funding
5.6M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About DotBio

DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore’s Nanyang Technological University. For more information visit www.dotbiopharma.com

DotBio Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

DotBio Org Chart

Sample employees and titles
Name Title Contact
Erica Ceccarello, Phd, Capm Scientist at Dotbio Pte Ltd
View
Haolin Sung Venture Capitalist
Email
Carl Firth Partner, Panacea Venture
View
Lui Ke Xin Business Development Executive
Email

Employees by Management Level

Individual contributor 6 profiles
Executive 2 profiles
Associate / junior 2 profiles
Intern / trainee 2 profiles

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0
Executive 1 1 0

DotBio Tech Stack

Data / AI 2 profiles

Compare Similar Companies to DotBio